SCHEMBL4660552

SCHEMBL4660552

O=C(CNC(=O)O)Cc1cccc(OC(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.54
MAPK14 Q16539 1/20 0.53
CETP P11597 3/20 0.49
CNR1 P21554 1/20 0.47
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
KDM5A P29375 1/20 0.46
KDM4C Q9H3R0 1/20 0.46
KDM5B Q9UGL1 1/20 0.46
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP14 P50281 1/20 0.44
ADAM17 P78536 1/20 0.44
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
GPR139 Q6DWJ6 1/20 0.43
GLS O94925 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28475012 0.85 VNN1 (0.56) VNN1MAPK14CETPCNR1ROCK2
SCHEMBL27834591 0.85 VNN1 (0.54) VNN1MAPK14CETPCNR1ROCK2
SCHEMBL1295167 0.84 VNN1 (0.54) VNN1MAPK14CETPCNR1ROCK2
SCHEMBL761677 0.81 MAPK14 (0.54) VNN1MAPK14CETPCNR1ROCK2
SCHEMBL12731532 0.80 VNN1 (0.52) VNN1MAPK14CETPCNR1ROCK2
Hydrochloric Acid SCHEMBL2525556 0.80 MAPK14 (0.53) VNN1MAPK14CETPCNR1ROCK2
SCHEMBL4659471 0.79 MEN1 (0.58) MAPK14FFAR1
SCHEMBL4659358 0.77 CTSD (0.41) EPHX2
SCHEMBL21981021 0.77 AOC2 (0.51) VNN1MAPK14CNR1ROCK2ROCK1
SCHEMBL378549 0.77 VNN1 (0.52) VNN1MAPK14CETPCNR1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004166-A2 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES LA JOLLA PHARMACEUTICAL COMPANY (US) 2008-12-24 EP disclosed
WO-2007120528-A2 INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES LA JOLLA PHARMACEUTICAL COMPANY (US) 2007-10-25 WO disclosed